by Gus Iversen
, Editor in Chief | December 30, 2015
15: Taking a page from ancient texts to understand superbugs 4/6/2015
Researchers from the University of Nottingham in England added unexpected insight to our understanding of antibiotic-resistant superbugs by killing them with a recipe from a 1,000 year old leather-bound book of cures
14: Medical device tax suspended for two years 12/23/2015
For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
Just before Christmas, Congress passed a two-year suspension of the 2.3 percent medical device tax
in year-end legislation. While that's good news for device companies, (particularly the smaller ones struggling to compete) it is also a hit for the ACA. Like so many things, the ultimate outcome will depend in large part on the next U.S. president.
13: Better prostate cancer detection with PET than MR 8/21/2015
Researchers from the University of Wisconsin School of Medicine and Public Health discovered that PET can detect a fast-growing primary prostate cancer better than MR and is also better at differentiating it from benign prostate lesions
. They hope this could eventually replace the traditional ultrasound-guided 12-core biopsy.
12: Here come the MR-guided linacs 1/23/2015
In January, Philips and Elekta announced a partnership to create an MR-guided linear accelerator
. Niklas Savander, Elekta's president and CEO, expects that monitoring stereotactic radiotherapy with MR as it's happening will become the standard of care within 10 years. In October, MD Anderson signed off to install the first such system in the U.S. early next year
11: King, Burwell, and the pursuit of loopholes in the ACA 3/5/2015
The nation was enraptured by the oral arguments in King versus Burwell
. There is a passage in the ACA that specifies health care subsidies are available through an, "exchange established by the state," which — if taken on its own and separate from the rest of the health law — may have implied that states without their own markets should not receive federal subsidies. The verdict, delivered in June, concluded it did not.
10: Defining the risks of repeat Gadolinium exams 6/26/2015
A class of contrast agent that is used for millions of MR exams every year can cause “significant and persistent” MR abnormalities over time
, according to a study published in the journal Investigative Radiology
. The research, conducted on rats, could have major implications on the future of MR imaging.